Geode Capital Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
|
|||||
|
2025
Q1 | $1.13M | Buy |
|
|||||
|
2024
Q4 | $1.26M | Buy |
|
|||||
|
2024
Q3 | $1.31M | Buy |
|
|||||
|
2024
Q2 | $821K | Sell |
|
|||||
|
2024
Q1 | $1.65M | Buy |
|
|||||
|
2023
Q4 | $2.93M | Buy |
|
|||||
|
2023
Q3 | $4.73M | Buy |
|
|||||
|
2023
Q2 | $9.39M | Buy |
|
|||||
|
2023
Q1 | $9.27M | Buy |
|
|||||
|
2022
Q4 | $8.91M | Buy |
|
|||||
|
2022
Q3 | $9.67M | Buy |
|
|||||
|
2022
Q2 | $4.18M | Buy |
|
|||||
|
2022
Q1 | $8.61M | Sell |
|
|||||
|
2021
Q4 | $10.3M | Buy |
|
|||||
|
2021
Q3 | $6.65M | Sell |
|
|||||
|
2021
Q2 | $26.4M | Buy |
|
|||||
|
2021
Q1 | $20M | Buy |
|
|||||
|
2020
Q4 | $21.7M | Buy |
|
|||||
|
2020
Q3 | $22.6M | Buy |
|
|||||
|
2020
Q2 | $3.51M | Buy |
|
|||||
|
2020
Q1 | $2.36M | Buy |
|
|||||
|
2019
Q4 | $2.14M | Buy |
|
|||||
|
2019
Q3 | $2.2M | Buy |
|
|||||
|
2019
Q2 | $1.48M | Buy |
|
|||||
|
2019
Q1 | $1.91M | Buy |
|
|||||
|
2018
Q4 | $1.07M | Buy |
|
|||||
|
2018
Q3 | $1.72M | Sell |
|
|||||
|
2018
Q2 | $1.95M | Sell |
|
|||||
|
2018
Q1 | $1.67M | Buy |
|
|||||
|
2017
Q4 | $2.12M | Buy |
|
|||||
|
2017
Q3 | $2.75M | Buy |
|
|||||
|
2017
Q2 | $1.92M | Buy |
|
|||||
|
2017
Q1 | $1.87M | Buy |
|
|||||
|
2016
Q4 | $1.56M | Buy |
|
|||||
|
2016
Q3 | $1.72M | Buy |
|
|||||
|
2016
Q2 | $2.61M | Buy |
|
|||||
|
2016
Q1 | $2.04K | Buy |
|
|||||
|
2015
Q4 | $2.63M | Buy |
|
|||||
|
2015
Q3 | $1.97M | Buy |
|